Sandbox JA: Difference between revisions
Jump to navigation
Jump to search
Joao Silva (talk | contribs) No edit summary |
Joao Silva (talk | contribs) No edit summary |
||
| Line 1: | Line 1: | ||
==Medical Therapy== | ==Medical Therapy== | ||
The treatment of anthrax infection includes antimicrobial and antitoxin agents. This treatment and postexposure prophylaxis differs from other bacterial infections because: | The treatment of [[anthrax]] infection includes [[antimicrobial]] and [[antitoxin]] agents. This treatment and postexposure [[prophylaxis]] differs from other [[bacterial infections]] because: | ||
* Production of toxin | * Production of [[toxin]] | ||
* Potential | * Potential [[antibiotic resistance]] | ||
* Frequent occurrence of meningitis | * Frequent occurrence of [[meningitis]] | ||
* Presence of latent spores must be taken into account when selecting postexposure prophylaxis | * Presence of latent [[spores]] must be taken into account when selecting postexposure [[prophylaxis]] or a combination of [[antibiotics]] for treatment of [[anthrax]]. | ||
==Antimicrobial Treatment== | ==Antimicrobial Treatment== | ||
Revision as of 14:26, 17 July 2014
Medical Therapy
The treatment of anthrax infection includes antimicrobial and antitoxin agents. This treatment and postexposure prophylaxis differs from other bacterial infections because:
- Production of toxin
- Potential antibiotic resistance
- Frequent occurrence of meningitis
- Presence of latent spores must be taken into account when selecting postexposure prophylaxis or a combination of antibiotics for treatment of anthrax.